Immunomonitoring in immunosuppressed patients with pneumonia

Immunomonitoring in immunosuppressed patients with pneumonia - IDES

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00010546

Enrollment

1000

Registered

2016-05-30

Start date

2016-03-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C92.00 Z94.81 D90 Z94.80

Interventions

Group 1: Immune cells from immunosuppressed cancer patients are analysed before, during and after the immunosuppression using flow-cytometry and ELISA to detect specific defects with a higher risk for

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: age >18 years, written informed consent, iatrogenic or disease-related immunosuppression or opportunistic infection suggesting an underlying immunosuppression

Exclusion criteria

Exclusion criteria: <18 years, pregnancy, no consent, participation in conflicting study

Design outcomes

Primary

Measure	Time frame
Detection of a predisposing immunodeficiency with an increased risk for pneumonias in immunocompromised patients using flow cytometry	—

Secondary

Measure	Time frame
cytokine analysis (ELISA)	—

Countries

Germany

Contacts

Public ContactMarie von Lilienfeld-Toal

Klinik für Innere Medizin II, Universitätsklinikum Jena

Marie.von_Lilienfeld-Toal@med.uni-jena.de03641-9324210

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026